ChoA Pharmaceutical Co., LTD. (KOSDAQ: 034940)

ChoA Pharmaceutical Co., LTD. Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	5,814	2,047	4,526	5,749	4,164	10,037
Short-Term Investments	1,548	1,538	1,537	1,587	1,706	1,526
Trading Asset Securities	860.71	775.02	2,386	2,849	3,176	2,926
Cash & Short-Term Investments	8,223	4,361	8,449	10,184	9,046	14,489
Cash Growth	35.80%	-48.39%	-17.04%	12.59%	-37.57%	1.17%
Accounts Receivable	18,784	20,230	22,727	20,884	21,546	24,078
Other Receivables	2,504	2,593	2,731	2,359	2,024	2,342
Receivables	22,539	23,900	27,603	24,867	25,039	28,095
Inventory	12,570	13,012	10,869	10,286	12,581	9,143
Prepaid Expenses	-	87.45	94.42	118.8	86.24	603.54
Other Current Assets	1,098	796.44	1,183	1,048	597.9	1,472
Total Current Assets	44,429	42,157	48,200	46,504	47,350	53,802
Property, Plant & Equipment	20,123	20,370	24,999	24,074	22,190	21,548
Long-Term Investments	2,888	2,792	2,935	3,678	3,163	2,592
Goodwill	-	-	-	46.78	46.78	-
Other Intangible Assets	817.42	803.4	806.87	795.5	583.5	637.33
Long-Term Accounts Receivable	1,054	1,054	1,054	-	-	-
Long-Term Deferred Tax Assets	1,378	1,499	1,401	945.32	1,671	1,244
Other Long-Term Assets	5,346	5,544	6,028	4,049	6,377	6,437
Total Assets	76,048	74,221	85,639	80,512	82,377	86,742
Accounts Payable	4,052	5,501	4,994	3,685	3,599	3,498
Accrued Expenses	-	3,494	2,765	2,775	2,664	2,576
Short-Term Debt	20,750	14,550	14,554	12,794	4,450	12,008
Current Portion of Long-Term Debt	90.07	-	-	-	3,700	-
Current Portion of Leases	743.48	633.15	637.5	684.07	745.25	592.61
Current Income Taxes Payable	-	-	-	-	-	23.75
Current Unearned Revenue	-	153.42	122.27	88.1	125.71	-
Other Current Liabilities	7,091	4,847	4,255	4,236	3,894	4,684
Total Current Liabilities	32,726	29,178	27,328	24,263	19,178	23,382
Long-Term Debt	1,979	1,105	1,904	1,000	-	3,950
Long-Term Leases	1,428	1,213	1,583	1,996	1,350	1,534
Other Long-Term Liabilities	3,384	3,422	3,417	3,542	3,615	3,403
Total Liabilities	40,533	35,464	34,231	32,129	25,634	34,993
Common Stock	15,490	15,490	15,490	15,490	15,490	14,155
Additional Paid-In Capital	63,621	63,621	63,621	63,621	63,502	58,366
Retained Earnings	-41,148	-38,175	-26,354	-29,255	-20,640	-19,837
Comprensive Income & Other	59.31	57.07	86.29	64.05	-50.28	372.07
Total Common Equity	38,023	40,993	52,844	49,920	58,302	53,056
Minority Interest	-2,508	-2,235	-1,436	-1,537	-1,559	-1,307
Shareholders' Equity	35,515	38,758	51,408	48,383	56,743	51,749
Total Liabilities & Equity	76,048	74,221	85,639	80,512	82,377	86,742
Total Debt	24,991	17,501	18,678	16,474	10,245	18,084
Net Cash (Debt)	-16,768	-13,141	-10,229	-6,289	-1,199	-3,595
Net Cash Per Share	-545.73	-424.17	-330.17	-203.02	-38.71	-126.99
Filing Date Shares Outstanding	30.73	30.98	30.98	30.98	30.98	28.31
Total Common Shares Outstanding	30.73	30.98	30.98	30.98	30.98	28.31
Working Capital	11,703	12,979	20,872	22,242	28,172	30,419
Book Value Per Share	1237.39	1323.22	1705.75	1611.38	1881.94	1874.10
Tangible Book Value	37,205	40,190	52,037	49,078	57,672	52,419
Tangible Book Value Per Share	1210.79	1297.29	1679.70	1584.20	1861.59	1851.58
Land	8,811	8,864	9,408	9,329	7,060	4,740
Buildings	3,842	14,739	18,178	18,129	17,637	17,637
Machinery	5,433	30,233	26,893	26,807	27,563	26,775
Construction In Progress	-	7.24	4,157	1,430	191.73	70.91

Source: S&P Capital IQ. Standard template. Financial Sources.